Search for: "Eli, Inc." Results 361 - 380 of 1,001
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
UMinnesota loses at CAFC. "Blaze marks" interpreted.
8 Mar 2023, 2:51 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1350−52 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Innovator Liability at 100
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Industry Tries Again For Clarity Concerning Off-Label Promotion
8 Jul 2011, 11:04 am by Bexis
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Title Company Owner Admits Stealing $5M Intended to Pay Off Prior Mortgages
7 Nov 2013, 4:02 pm by Allison Tussey
Macaluso, who owned and operated Affinity Title Agency, Inc., pleaded guilty to an accusation charging him with theft and misconduct by a corporate official, both in the second degree, before Superior Court Judge Edward A. [read post]
Mortgage Fraud Blog - http://mortgagefraudblog.com/
Centocor v. Abbott: Written Description and Antibody Claims
24 Feb 2011, 10:14 pm by Jason Rantanen
See Eli Lilly, 119 F.3d at 1566-69. [read post]
Patently-O - http://www.patentlyo.com/patent/
Pharma & Biotech Global Week in Review 11 August 2010 from IP Think Tank
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Drug Company May Use Its Sales Force To Sell Two Rival Products for Now; Irreparable Harm the Issue on Appeal
12 Jul 2011, 6:59 am by randal shaheen
Natural Resources Defense Council, Inc., the core issue in the case -- and a crucial issue for practitioners. [read post]
Consumer Advertising Law Blog - http://www.consumeradvertisinglawblog.com/
Monster imagery implies danger; no survey required to get preliminary injunction against it
21 Jun 2018, 12:50 pm by Rebecca Tushnet
Eli Lilly & Co. v. [read post]
43(B)log - http://tushnet.blogspot.com/
In re Alonso: one species fails to support a genus claim
6 Nov 2008, 3:08 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Defamation/dilution suit against critic survives motion to dismiss
30 Nov 2011, 6:22 pm by Rebecca Tushnet
Doctor's Data, Inc. v. [read post]
43(B)log - http://tushnet.blogspot.com/
Unethical Indemnity Issues in Settlement Releases
22 Oct 2021, 9:16 am by Elie Maalouf
By: Elie A. [read post]
Medical Malpractice and Personal Injury Blog - https://www.arbd.com/blog/
Speech, politics, and the corporate form
22 Jan 2010, 12:23 pm by Howard Wasserman
GM, Disney, Delmar Contracting, Inc. [read post]
PrawfsBlawg - http://prawfsblawg.blogs.com/prawfsblawg/
Center for Intellectual Property Law and Innovation Holds Third Annual Symposium
8 Apr 2014, 8:02 am
In ABC, Inc. v. [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Pharma & Biotech Global Week in Review 17 Apr 2009 from IP Think Tank
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs) Gleevec / Glivec (Imatinib) – Novartis alpha crystalline form patent invalidated at pre – grant opposition (PatentCircle) Levaquin (Levofloxacin) - Daiichi Sankyo Co. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Diabetes Drug Byetta Linked To Kidney Problems And Cases Of Renal Failure
3 Nov 2009, 2:35 pm by Tom Lamb
On November 2, 2009 Amylin Pharmaceuticals, Inc., and Eli Lilly and Company issued their joint statement in response to the FDA on BYETTA® (exenatide) injection. [read post]
Drug Injury Watch - http://www.drug-injury.com/druginjurycom/
Federal Circuit's En Banc Review of Written Description Requirement Does Not Constitute "Intervening Change" or Alter "Existing Standards"
24 Feb 2010, 6:40 am by The Docket Navigator
Eli Lilly & Co., Fed. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
HHS/DOJ Report Provides Overview of Government's Enforcement Efforts in Healthcare Sector
26 May 2010, 4:09 am by Anthony Lake
Notable settlements in this area include Pfizer, Inc., which, at $2.3 billion, constitutes the largest healthcare fraud settlement in U.S. history, Eli Lilly Company; Abbott Laboratories, Inc.; and Bayer Healthcare, LLC. [read post]
Federal Criminal Defense Blog - http://www.federalcriminaldefenseblog.com/
FDA Warns 14 Drugmakers Over Misleading Ads
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
Personal Injury and Social Security Disability Blog - http://www.injury-and-disability.com/
Attorney, Client Frivolous? Wrong Defendant Sued
27 Sep 2007, 4:56 am
Felton & Associates Defendant: Eli D. [read post]
New York Attorney Malpractice Blog - http://blog.bluestonelawfirm.com/
Comments In For Proposed Rule Changes to Patent Appeals
8 Nov 2007, 9:50 am
[PDF] Amylin Pharmaceuticals, Inc. [read post]
Patent Baristas - http://www.patentbaristas.com